News

FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment
The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...
NBC New York4mon
FDA approves Johnson & Johnson's nasal spray for depression as standalone treatment
The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in ... new major depression treatment to win FDA approval in more than three decades.
UPI4mon
FDA approves Spravato, first monotherapy nasal spray to treat depression
Johnson & Johnson's Spravato ... oral antidepressants," Martin added. The FDA approval of Spravato comes after a controlled study showed the nasal spray provided rapid improvement in the ...
Hosted on MSN4mon
FDA approves Johnson & Johnson’s nasal spray for depression as stand-alone treatment
The Food and Drug Administration approved Johnson & Johnson's nasal spray to be used alone in adults ... new major depression treatment to win FDA approval in more than three decades.
AOL4mon
FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment
The nasal spray was first approved by the FDA in 2019 as a supplemental treatment ... as an antidepressant effect is not known, says Johnson & Johnson. According to the news release, patients ...